Grants and Contributions:
Title:
Rhinoclear US Market Launch – Phase 1
Agreement Number:
948049
Agreement Value:
$33,600.00
Agreement Date:
Apr 14, 2020 - Dec 31, 2020
Description:
This project will support Rhinoclear’s initial market penetration into USA retail pharmacy distribution, exhibiting at the premier chain drug stores event, obtaining US FDA registration and initial online consumer awareness efforts.
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Calgary, Alberta, CA T2N 4G3
Reference Number:
172-2020-2021-Q1-948049
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
804018471
Recipient Type:
For-profit organization
Recipient's Legal Name:
Alberta Veterinary Laboratories Ltd.
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
325410